| Post-Op Quality of Life After Colorectal Surgery (NCT00468455) | University Hospitals Cleveland Medical Center | 2005-10-01 |
| Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors (NCT00599924) | Pfizer | 2005-09-01 |
| Implementation of a New Strategy to Identify HNPCC Patients (NCT00141466) | Radboud University Medical Center | 2005-09-01 |
| Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients (NCT00398333) | Hospital Clinic of Barcelona | 2005-06-01 |
| 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology (NCT00207298) | British Columbia Cancer Agency | 2005-06-01 |
| Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB (NCT00236249) | Assistance Publique - Hôpitaux de Paris | 2005-05-01 |
| CHOICE: Communicating Health Options Through Information and Cancer Education (NCT00134589) | Centers for Disease Control and Prevention | 2005-04-01 |
| Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer (NCT00320320) | Gachon University Gil Medical Center | 2005-04-01 |
| Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 (NCT00844064) | Isarna Therapeutics GmbH | 2005-01-01 |
| The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases (NCT00145665) | Radboud University Medical Center | 2005-01-01 |
| Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors (NCT00168987) | Charite University, Berlin, Germany | 2005-01-01 |
| Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases (NCT00156975) | Arbeitsgruppe Lebermetastasen und Tumoren | 2004-11-01 |
| Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer (NCT00311272) | University Hospital, Gentofte, Copenhagen | 2004-11-01 |
| Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy (NCT00083720) | Eli Lilly and Company | 2004-10-01 |
| An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation (NCT00132704) | Memorial Sloan Kettering Cancer Center | 2004-08-01 |
| Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed (NCT00259844) | Cancer Research UK | 2004-06-01 |
| Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases (NCT00083785) | Light Sciences LLC | 2004-05-01 |
| Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course (NCT01086683) | Danish Cancer Society | 2004-05-01 |
| Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer (NCT00220246) | Radboud University Medical Center | 2004-03-01 |
| Celebrex With Preoperative Chemoradiation - Rectal Cancer (NCT00188565) | University Health Network, Toronto | 2004-03-01 |
| Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer (NCT00123760) | AHS Cancer Control Alberta | 2004-02-01 |
| Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer (NCT00199862) | Memorial Sloan Kettering Cancer Center | 2004-02-01 |
| Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments. (NCT00077987) | Pfizer | 2003-12-01 |
| Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment (NCT00078468) | Pfizer | 2003-12-01 |
| Establishment of a Tumor Bank for Blood Samples (NCT01763125) | Medical University of Vienna | 2003-11-01 |
| Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer (NCT00291486) | Ludwig Institute for Cancer Research | 2003-10-01 |
| Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases (NCT00068068) | Light Sciences LLC | 2003-10-01 |
| Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning (NCT00184782) | Radboud University Medical Center | 2003-09-01 |
| Establishment of a Tumor Bank for Tissue Samples (NCT01789229) | Medical University of Vienna | 2003-09-01 |
| Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. (NCT00065117) | AstraZeneca | 2003-09-01 |
| Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer (NCT00051688) | Chiron Corporation | 2003-06-01 |
| Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine. (NCT00101686) | Pfizer | 2003-02-01 |
| A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer (NCT00055419) | Eli Lilly and Company | 2003-02-01 |
| An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer (NCT00054912) | Epimmune | 2003-02-01 |
| A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF) (NCT00190515) | Haruhiko Fukuda | 2003-02-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. (NCT00056459) | Novartis | 2003-02-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer (NCT00056446) | Novartis Pharmaceuticals | 2003-01-01 |
| Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver (NCT00035919) | University of Southern California | 2002-11-01 |
| Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). (NCT00140036) | Pfizer | 2002-09-01 |
| Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma (NCT00044863) | Eli Lilly and Company | 2002-08-01 |
| XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy (NCT00272051) | Sanofi | 2002-07-01 |
| Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer (NCT00034034) | National Center for Complementary and Integrative Health (NCCIH) | 2002-06-01 |
| A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer (NCT00040391) | Celgene Corporation | 2002-06-01 |
| EPO906 Therapy in Patients With Advanced Colorectal Cancer (NCT00035087) | Novartis Pharmaceuticals | 2002-05-01 |
| For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy (NCT00037180) | Pfizer | 2002-04-01 |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer (NCT00036517) | PhytoCeutica | 2002-02-01 |
| A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer (NCT00034827) | Pfizer | 2002-01-01 |
| Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer (NCT00143403) | Pfizer | 2001-12-01 |
| Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer (NCT00506168) | National Cancer Center, Korea | 2001-11-01 |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver (NCT00041808) | FeRx | 2001-07-01 |
| Massage Therapy for Cancer-Related Fatigue (NCT00039793) | National Center for Complementary and Integrative Health (NCCIH) | 2001-03-01 |
| Institut Paoli Calmettes Colorectal Cancer Database (NCT02869503) | Institut Paoli-Calmettes | 2001-01-01 |
| Unprepped CT Colonography (NCT00586053) | Mayo Clinic | 2000-08-01 |
| Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer (NCT02198274) | Boehringer Ingelheim | 2000-02-01 |
| Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer (NCT00041652) | Gilead Sciences | 2000-02-01 |
| Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial (NCT00623883) | National Naval Medical Center | 1999-01-01 |
| A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer (NCT00001428) | National Cancer Institute (NCI) | 1995-02-01 |
| Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy (NCT01538680) | Bayer | |
| Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies (NCT00081536) | Aronex Pharmaceuticals | |
| Study Evaluating EKB-569 in Advanced Colorectal Cancer (NCT00072748) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery (NCT00041691) | Gilead Sciences | |
| Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer (NCT00780988) | Stanford University | |
| Preop CPET Testing and Exercise Training in Colorectal Patients (NCT01924897) | University of East Anglia | |
| Study Evaluating MAC-321 in Colorectal Cancer (NCT00063427) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies (NCT00043199) | Aronex Pharmaceuticals | |